ATC code C05

From Wikipedia, the free encyclopedia
Jump to: navigation, search
ATC codes
C Cardiovascular system
C01 Cardiac therapy
C02 Antihypertensives
C03 Diuretics
C04 Peripheral vasodilators
C05 Vasoprotectives
C07 Beta blocking agents
C08 Calcium channel blockers
C09 Agents acting on the renin-angiotensin system
C10 Lipid modifying agents

ATC code C05 Vasoprotectives is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup C05 is part of the anatomical group C Cardiovascular system.[1]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: QC05...[2]

National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

Contents

[edit] C05A Agents for treatment of hemorrhoids and anal fissures for topical use

[edit] C05AA Corticosteroids

C05AA01 Hydrocortisone
C05AA04 Prednisolone
C05AA05 Betamethasone
C05AA06 Fluorometholone
C05AA08 Fluocortolone
C05AA09 Dexamethasone
C05AA10 Fluocinolone acetonide
C05AA11 Fluocinonide
C05AA12 Triamcinolone

[edit] C05AB Antibiotics

[edit] C05AD Local anesthetics

C05AD01 Lidocaine
C05AD02 Tetracaine
C05AD03 Benzocaine
C05AD04 Cinchocaine
C05AD05 Procaine
C05AD06 Oxetacaine
C05AD07 Pramocaine

[edit] C05AE Muscle relaxants

C05AE01 Glyceryl trinitrate
C05AE02 Isosorbide dinitrate

[edit] C05AX Other agents for treatment of hemorrhoids and anal fissures for topical use

C05AX01 Aluminium preparations
C05AX02 Bismuth preparations, combinations
C05AX03 Other preparations, combinations
C05AX04 Zinc preparations
C05AX05 Tribenoside

[edit] C05B Antivaricose therapy

[edit] C05BA Heparins or heparinoids for topical use

C05BA01 Organo-heparinoid
C05BA02 Sodium apolate
C05BA03 Heparin
C05BA04 Pentosan polysulfate sodium
C05BA51 Heparinoid, combinations
C05BA53 Heparin, combinations

[edit] C05BB Sclerosing agents for local injection

C05BB01 Monoethanolamine oleate
C05BB02 Polidocanol
C05BB03 Invert sugar
C05BB04 Sodium tetradecyl sulfate
C05BB05 Phenol
C05BB56 Glucose, combinations

[edit] C05BX Other sclerosing agents

C05BX01 Calcium dobesilate
C05BX51 Calcium dobesilate, combinations

[edit] C05C Capillary stabilising agents

[edit] C05CA Bioflavonoids

C05CA01 Rutoside
C05CA02 Monoxerutin
C05CA03 Diosmin
C05CA04 Troxerutin
C05CA05 Hidrosmin
C05CA51 Rutoside, combinations
C05CA53 Diosmin, combinations
C05CA54 Troxerutin, combinations

[edit] C05CX Other capillary stabilising agents

C05CX01 Tribenoside
C05CX02 Naftazone
C05CX03 Hippocastani semen

[edit] References

  1. ^ "ATC/DDD Index 2012". WHO Collaborating Centre for Drug Statistics Methodology. http://www.whocc.no/atc_ddd_index/. 
  2. ^ "ATCvet Index 2012". WHO Collaborating Centre for Drug Statistics Methodology. http://www.whocc.no/atcvet/atcvet_index/. 
Personal tools
Namespaces

Variants
Actions
Navigation
Interaction
Toolbox
Print/export
Languages